| Issue |
Section |
Title |
File |
| Vol 10, No 1 (2020) |
ORIGINAL REPORT |
Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation |
(Rus)
|
| Vol 10, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS |
Tall-cell variant of papillary thyroid carcinoma: literature review and case reports |
(Rus)
|
| Vol 10, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS |
Side skin reactions of multikinase inhibitors in treatment of thyroid cancer |
(Rus)
|
| Vol 11, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS |
Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice |
(Rus)
|
| Vol 11, No 4 (2021) |
REVIEW |
Historical aspects and modern concepts in the treatment of patients with differentiated thyroid cancer, refractory to radioactive iodine therapy |
(Rus)
|
| Vol 12, No 2 (2022) |
ORIGINAL REPORT |
Survival analysis of patients with advanced metastatic differentiated thyroid cancer |
(Rus)
|
| Vol 13, No 1 (2023) |
REVIEW |
Follow-up after radioiodine remnant ablation in differentiated thyroid cancer: the view of nuclear medicine physician |
(Rus)
|
| Vol 13, No 4 (2023) |
DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS |
“Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use |
(Rus)
|
| Vol 14, No 1 (2024) |
METHODOLOGICAL RECOMMENDATIONS |
Guidelines for radioiodine therapy in differentiated thyroid cancer and post-therapeutic follow-up |
(Rus)
|
| Vol 14, No 2 (2024) |
TOPICAL |
Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness |
(Rus)
|
| Vol 14, No 4 (2024) |
REVIEW |
Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new? |
(Rus)
|
| Vol 15, No 1 (2025) |
DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS |
Advanced metastatic radioiodine refractory differentiated thyroid cancer: current treatment and dynamic surveillance issues |
(Rus)
|
| Vol 15, No 1 (2025) |
REVIEW |
Selpercatinib in the treatment of medullary and radioiodine-refractory differentiated thyroid cancer with RET mutation (literature review) |
(Rus)
|
